Notícias e Atividades da Cumberland Pharmaceuticals

Cumberland Pharmaceuticals é uma empresa listada sob o símbolo CPIX (US).

Veja o organograma con seus 13 executivos principais

Biografias mais buscadas da Cumberland Pharmaceuticals

• A.J. Kazimi, Chairman and Chief Executive Officer
• Martin Brown, Director
• Caroline Young, Director

Recentes movimentos de executivos em Cumberland Pharmaceuticals

• James Jones, Director, deixou a Companhia  (Notícia publicada em 2 de julho de 2026).
• Chris Bitterman, Vice President of Sales & Marketing, deixou a Companhia  (Notícia publicada em 2 de julho de 2026).

Criar um alerta
para seguir os movimentos de executivos da Cumberland Pharmaceuticals.

Cumberland Pharmaceuticals possui 1.919 concorrentes concorrentes Sanofi (França), Moderna (Estados Unidos) e Eli Lilly (Estados Unidos).

Popular M&A news in Farmacêutica

• Eli Lilly has announced the acquisition of AtaiBeckley  (publicado em 17 de julho de 2026).
• Agenus acaba de anunciar uma arrecadação de fundos de 340 milhões de dólares. (publicado em 17 de julho de 2026).
• GSK adquiriu Nuvalent (publicado em 17 de julho de 2026).

Outros contatos sugeridos na indústria do Farmacêutica

• David Ricks - President, Chief Executive Officer and Chairman of the Board da Eli Lilly
• Richard Saynor - Chief Executive Officer da Sandoz
• Joaquin Duato - Chief Executive Officer and Chairman of the Board da Johnson & Johnson

Saiba mais sobre a indústria do Farmacêutica

Últimos comunicados de imprensa de Cumberland Pharmaceuticals

• In the News | Cumberland Pharmaceuticals, Inc.
• Newly Published Literature Supports Use Of Caldolor® For Postoperative Pain And Reduction Of Opioid Use | Cumberland Pharmaceuticals, Inc.
• Cumberland Pharmaceuticals Reports Second Quarter 2020 Financial Results & Company Update | Cumberland Pharmaceuticals, Inc.
• Cumberland Pharmaceuticals To Announce Second Quarter 2020 Financial Results | Cumberland Pharmaceuticals, Inc.
• Caldolor® Demonstrates Significant Reduction Of Opioid Use In Orthopedic Trauma Patients | Cumberland Pharmaceuticals, Inc.
• Press Releases | Cumberland Pharmaceuticals, Inc.
• New Publication Reveals Real-World Usage of Vibativ® In Patients With Bacteremia Or Endocarditis | Cumberland Pharmaceuticals, Inc.
• Cumberland Pharmaceuticals Reports First Quarter 2020 Financial Results & Company Update | Cumberland Pharmaceuticals, Inc.
• Cumberland Pharmaceuticals To Announce First Quarter 2020 Financial Results | Cumberland Pharmaceuticals, Inc.
• Vibativ® Sustained Potency Confirmed In Two Surveillance Studies | Cumberland Pharmaceuticals, Inc.
• View more press releases Close

Redes sociais sobre Cumberland Pharmaceuticals

• Cumberland Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
• Cumberland Pharmaceuticals na LinkedIn, X (Twitter) e YouTube